ACHE

ACHE 詳細

英語名Acetylcholinesterase市販薬剤の数27
治験薬の数31ターゲットの別称EC:3.1.1.7,EC 3.1.1,Acetylcholinesterase (YT Blood Group),Acetylcholinesterase (Cartwright Blood Group),Yt Blood Group,Apoptosis-Related Acetylcholinesterase,Acetylcholinesterase,EC 3.1.1.7,ARACHE,N-ACHE,ACEE,AChE,YT
研究&開発段階Approved
英語名Acetylcholinesterase
ターゲットの別称EC:3.1.1.7,EC 3.1.1,Acetylcholinesterase (YT Blood Group),Acetylcholinesterase (Cartwright Blood Group),Yt Blood Group,Apoptosis-Related Acetylcholinesterase,Acetylcholinesterase,EC 3.1.1.7,ARACHE,N-ACHE,ACEE,AChE,YT
市販薬剤の数27
治験薬の数31
研究&開発段階Approved

ACHE 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • Human (1)

  • タグ

    His Tag (1)

  • マーカー

    Unconjugated (1)

製品番号発現システム製品説明タンパク質の構造純度特性
AHE-H52H3
Human
HEK293
Human ACHE / Acetylcholinesterase Protein, His Tag (active enzyme)
総数量1
  • 1

ACHEバックグランド

The enzyme acetylcholinesterase, also known as AChE or acetylhydrolase, is the primary cholinesterase in the body. It is a serine hydrolase whose primary function is to catalyzes the breakdown of acetylcholine(ACh) and of some other choline esters that function as neurotransmitters. AChE is found at mainly neuromuscular junctions and in chemical synapses of the cholinergic type, where its activity serves to terminate synaptic transmission. Acetylcholine deficit has been found in Alzheimer's disease (AD) ans is associated with cognetive decline. Therefore, AChE has been reported to be a viable therapeutic target for the treatment of AD and other dementias. To this end, acetylcholinesterase inhibitors (AChEIs) are commonly used.

ACHE分子の別称

acetylcholinesterase (Yt blood group),Acetylcholinesterase,ACHE,apoptosis-related acetylcholinesterase,ARACHE,EC 3.1.1,EC 3.1.1.7,N-ACHE,Yt blood group,YT

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Donepezil/SolifenacinCPC-201Phase 3 ClinicalAllergan Plc, Cipla IncAlzheimer Disease; Dementia; Urologic Diseases
詳細
Botulinum toxin (CKD Bio)CKDB-501B; CKDB-501-B; CKDB-501A; CKDB-501-A; CKDB-501Phase 3 ClinicalCKD Bio CorpGlabellar lines; Spasm
詳細
BR-4001BNT-002; BR-4001Phase 3 ClinicalBoryung Pharmaceutical Co LtdAlzheimer Disease
詳細
Blarcamesine/Donepezil HydrochloridePhase 2 ClinicalAnavex Life Sciences CorpAlzheimer Disease
詳細
PregnenoloneNBI-113Phase 2 ClinicalNeurocrine Biosciences IncAlcoholism; Anxiety; Autism Spectrum Disorder; Autistic Disorder; Cocaine-Related Disorders; Depression; Depressive Disorder, Major; Low Back Pain; Menopausal symptoms; Schizophrenia; Stress Disorders, Post-Traumatic
詳細
FluoropezilDC-20; DC-511020Phase 2 ClinicalJiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of SciencesAlzheimer Disease
詳細
Pyridostigmine extended release (Kashiv BioSciences)K-127Phase 2 ClinicalKashiv BioSciences LLCBlepharoptosis; Fatigue Syndrome, Chronic; Musculoskeletal Diseases; Myasthenia Gravis; Post-Acute COVID-19 Syndrome; Urination Disorders
詳細
Donepezil long-acting Injection (Inventage Lab)IVL-3003Phase 2 ClinicalInventage Lab IncAlzheimer Disease
詳細
YY-003YY003; YY-003Phase 2 ClinicalChongqing Claruvis Pharmaceutical Co LtdGlabellar lines
詳細
AT-004(Arctic Therapeutics)AT-004(Arctic Therapeutics)Phase 2 ClinicalArctic Therapeutics InternationalAcne Vulgaris; Dermatitis, Atopic; Psoriasis; Rosacea
詳細
Galantamine/MetforminRJx-01Phase 2 ClinicalRejuvenate Biomed NVMuscle Weakness; Muscular Atrophy; Sarcopenia
詳細
Huperizine-A (Biscayne Pharmaceuticals)BIS-001; INS-001; XEL-001-HP; SPN-817; BIS-001-ER; XEL-001-HG; Hup-APhase 2 ClinicalHarvard UniversityEpilepsy, Complex Partial; Seizures
詳細
EX-039EX-039Phase 2 ClinicalExcelsior CorpAlzheimer Disease
詳細
donepezil (Vyant Bio)VYNT-0126Phase 2 ClinicalVyant Bio IncRett Syndrome
詳細
YIV-906PHY-906; KD-018Phase 2 ClinicalPhytoceutica IncCarcinoma, Hepatocellular; Colorectal Neoplasms; Diarrhea; Hepatitis B; Liver Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms
詳細
AD-35AD-35Phase 2 ClinicalZhejiang Hisun Pharmaceutical Co LtdAlzheimer Disease
詳細
Edrophonium ChloridePhase 1 ClinicalTeligentMyasthenia Gravis
詳細
18F-flubatineFluorine-18-flubatine; flubatine-[18F]; 18F-flubatine; norchloro-fluoroepibatidine-[18F]Phase 1 ClinicalHelmholtz-Zentrum Dresden-RossendorfAlzheimer Disease
詳細
Phenserine tartrateDWJ301Phase 1 ClinicalQr PharmaAlzheimer Disease; Cognitive Dysfunction
詳細
Mecripyrine HydrochlorideSCR-1693; Y-1A; Y-1Phase 1 ClinicalJiangsu Simcere Pharmaceutical Co Ltd, NeuroDawn Pharmaceutical Co Ltd, Yantai Yene Pharma Co LtdAlzheimer Disease; Brain Neoplasms
詳細
Methanesulfonyl fluorideSNX-001Phase 1 ClinicalSenextaAlzheimer Disease
詳細
NB-02NB-02; DA-9803Phase 1 ClinicalDong-A ST Co LtdAlzheimer Disease; Lymphoma, Non-Hodgkin
詳細
NDC-011NDC-011Phase 1 ClinicalDr. Noah Biotech IncAmyotrophic Lateral Sclerosis
詳細
Donepel hydrochloride oral instant membrane(Sichuan Baili Pharma)Phase 1 ClinicalSichuan Baili Pharmaceutical Co LtdAlzheimer Disease
詳細
Donepezil Hydrochloride Oral Soluble Film(Shanxi Hcxf Pharma)Phase 1 ClinicalShanxi Hcxf Pharmaceutical Co LtdAlzheimer Disease
詳細
Donepezil Hydrochloride Oral Soluble Film(Hangzhou Heze Pharma)HZ007; HZ-007Phase 1 ClinicalHangzhou Heze Pharmaceutical Technology Co LtdAlzheimer Disease; Dementia
詳細
Huperzine A Oral Solution(Universal Pharmaceutical Group)Phase 1 ClinicalUniversal Pharmaceutical Group Co LtdMyasthenia Gravis
詳細
Donepezil transdermal patch(Dong-A ST)DA-5207Phase 1 ClinicalDong-A ST Co Ltd
詳細
HHT-201HHT-201Phase 1 ClinicalZhejiang Huahai Pharmaceutical Co LtdAlzheimer Disease; Hypertension
詳細
Rivastigmine (Lachesis Biosciences Pty)ClinicalLachesis Biosciences Pty LtdNerve Degeneration
詳細
donepezil (Daewoong)DWJ-1365ClinicalDaewoong Pharmaceutical Co LtdAlzheimer Disease
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Galantamine HydrobromideGP-37267; R-113675ApprovedAverTox, Nivalin, Reminyl, Razadyne, Reminyl XLMainland ChinaAlzheimer Diseasenull1981-01-01AIDS Dementia Complex; Alzheimer Disease; Autistic Disorder; Bipolar Disorder; Brain Diseases; Cocaine-Related Disorders; Cognition Disorders; Dementia; Dementia, Vascular; Depressive Disorder, Major; Fasting; Frontotemporal Dementia; Insulin Resistance; Lewy Body Disease; Memory; Mental Disorders; Nervous System Diseases; Obesity; Schizophrenia; Stroke; Subarachnoid Hemorrhage; Tobacco Use Disorder; Vascular Diseases
詳細
Neostigmine BromideApprovedProstigminMainland ChinaFlatulence; Urinary Retention; Myasthenia GravisShanghai Sine Pharmaceutical Laboratories Co Ltd1995-01-01Delayed Emergence from Anesthesia; Flatulence; Headache; Hypertension; Hyperventilation; Hypoxia; Myasthenia Gravis; Tachycardia; Urinary Retention
詳細
MetrifonateBay-a-9826; Bayer-L-1359ApprovedProMem, Memobay, BilarcilSchistosomiasis
詳細
Rivastigmine TartrateSDZ-212-713; SDZ 212713; SDZ-ENA-713; ONO-2540; ENA-713; ENA-713DApprovedNovartis Pharma AgExelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能EUAlzheimer Disease; Parkinson Disease; DementiaNovartis Europharm Ltd1998-05-11Alzheimer Disease; Anticholinergic Syndrome; Brain Injuries, Traumatic; Cocaine-Related Disorders; Cognition Disorders; Delirium; Dementia; Dementia, Vascular; Down Syndrome; Neurobehavioral Manifestations; Parkinson Disease; Substance-Related Disorders
詳細
Pyridostigmine BromideRo-1-5130ApprovedValeantRegonol, MestinonUnited StatesLambert-Eaton Myasthenic SyndromeBausch & Lomb (Singapore) Pvi Ltd1955-04-06Colonic Diseases; Constipation; Coronavirus Disease 2019 (COVID-19); Diabetes Mellitus; Dyskinesias; Fatigue Syndrome, Chronic; Fibromyalgia; Glycogen Storage Disease Type II; Heart Failure; HIV Infections; Hypotension, Orthostatic; Immunologic Deficiency Syndromes; Lambert-Eaton Myasthenic Syndrome; Myasthenia Gravis; Parkinson Disease; Poisoning; Postural Orthostatic Tachycardia Syndrome; Primary Dysautonomias; Scleroderma, Systemic; T-Lymphocytopenia, Idiopathic CD4-Positive
詳細
Dimebolin hydrochlorideBRN-0622478; PF-01913539; DMB-IApprovedBigespas LtdDimebonRussian FederationHypersensitivity; Rhinitis, Allergic; Dermatitis, Atopicnull1983-01-01Alzheimer Disease; Dementia; Dermatitis, Atopic; Huntington Disease; Hypersensitivity; Liver Failure; Rhinitis, Allergic
詳細
Donepezil HydrochlorideDKF-310; BNAG; E-2020; E-2022; (±)-E-2020; IVL-3003; GB-5001ApprovedEisai Co LtdMemac, Eranz, Memorit, Aricept Evess, Aricept, Aricept ODT, Aricept D, 安理申, ADLARITYUnited StatesAlzheimer DiseaseEisai Inc1996-11-25Alcoholism; Alzheimer Disease; Anorexia Nervosa; Anxiety Disorders; Aphasia; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Autistic Disorder; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; CNS Embryonal Tumor; Cognition Disorders; Cognitive Dysfunction; Delirium; Dementia; Dementia, Vascular; Depression; Diabetes Mellitus, Type 2; Down Syndrome; Fatigue; Fragile X Syndrome; Hearing Loss, Sensorineural; Ischemic Stroke; Lewy Body Disease; Memory Disorders; Migraine Disorders; Multiple Sclerosis; Neoplasms; Neurologic Manifestations; Neurotoxicity Syndromes; Osteoporosis; Parkinson Disease; Psychological Distress; Sleep Wake Disorders; Stroke; Subarachnoid Hemorrhage; Supranuclear Palsy, Progressive; Wounds and Injuries
詳細
Memantine Hydrochloride/Donepezil HydrochlorideADS-8704; D-797/D-324; CKD 355; BPS-034; BPDO-1603; MDX-8704ApprovedAllergan PlcArimenda, NamzaricUnited StatesAlzheimer DiseaseAbbvie Inc2014-12-23Alzheimer Disease
詳細
Huperzine ASPN-817ApprovedChinese Academy Of Sciences, Mayo Clinic哈伯因, 双益平Mainland ChinaAlzheimer DiseaseHenan Taloph Pharmaceutical Stock Co Ltd1994-01-01Alzheimer Disease; Brain Injuries, Traumatic; Epilepsy; Learning Disabilities; Memory Disorders; Schizophrenia; Seizures
詳細
Distigmine BromideBC-51ApprovedTorii Pharmaceutical Co LtdUbretidJapanDysuria; Myasthenia GravisTorii Pharmaceutical Co Ltd1967-09-05Dysuria; Esotropia; Glaucoma; Myasthenia Gravis
詳細
Pralidoxime Chloride2-PAM-chlorideApprovedBaxter International IncProtopam chlorideUnited StatesPoisoningBaxter Healthcare Corp1964-03-11Poisoning
詳細
Pralidoxime Iodide2-PAMI; NSC-7760; 2-PAM IodideApprovedJapanPoisoningSumitomo Dainippon1958-05-01Poisoning
詳細
Eserine SalicylateApprovedSynapton SR, Xalieve, AntiliriumDelirium; Glaucoma; Insulin Resistance; Pain, Postoperative; Psychotic Disorders
詳細
Neostigmine methylsulfateApprovedBloxiverz, Intrastigmina, Juvastigmin, Stiglyn, MetastigminJapanMyasthenia Gravis; Muscle Hypotoniakyowayakuhin Co1936-10-01Flatulence; Muscle Hypotonia; Myasthenia Gravis; Neuromuscular Blockade; Urinary Retention
詳細
Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6Approved新乐敦
詳細
Dextrose/Sodium Chloride/Potassium Chloride/Floxacillin sodiumApproved
詳細
Dextrose/Sodium Chloride/Potassium Chloride/AnthralinApproved
詳細
Dextrose/Sodium Chloride/Potassium Chloride/Pralidoxime ChlorideApproved
詳細
Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine SulfateApprovedPoisoning
詳細
Naphazoline Hydrochloride/Neostigmine methylsulfateApproved
詳細
Dihydrogalanthamine HydrobromideApprovedMainland ChinaHemiplegia; Sciaticanull1982-01-01Hemiplegia; Sciatica
詳細
Securinine NitrateApprovedFacial Paralysis; Poliomyelitis
詳細
Rivastigmine Twice Weekly Transdermal Patch (Luye Pharma)LY-03013; LY-30410; RID-TDSApprovedAcino International AGRivirec, 金斯明, Kingsmin, Rivalif®Mainland ChinaAlzheimer DiseaseLuye Pharma Group LtdAlzheimer Disease; Parkinson Disease
詳細
Glycopyrronium bromide/Neostigmine metilsulfateApprovedSintetica GmbhNovistig, PrevduoAustriaNeuromuscular BlockadeSintetica Gmbh2020-09-23Neuromuscular Blockade
詳細
Benzgalantamine gluconateGLN-1062; ALPHA-1062; ALPHA-1062IN; Alpha 1062; ALPHA-1062 IntranasalApprovedGalantos Pharma GmbHZunveylUnited StatesAlzheimer DiseaseAlpha Cognition Inc2024-07-26Alzheimer Disease; Brain Injuries, Traumatic; Cognitive Dysfunction
詳細
Atropine/Pralidoxime ChlorideApprovedMeridian Medical Technologies IncDUODOTEUnited StatesPoisoning; Organophosphate PoisoningMeridian Medical Technologies LLC2002-01-17Drug intoxications; Drug-Related Side Effects and Adverse Reactions; Organophosphate Poisoning; Poisoning
詳細
Acotiamide Hydrochloride HydrateZ-338; YM-443ApprovedZeriaAcofideJapanDyspepsianull2013-03-25Dyspepsia; Nausea
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8